FMS - Fresenius Medical Care AG & Co. KGaA

NYSE - NYSE Delayed price. Currency in USD
Show:
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
19,398,017
19,398,000
17,619,000
17,859,000
17,477,000
Cost of revenue
14,087,765
14,088,000
12,542,000
12,322,000
12,081,000
Gross profit
5,310,252
5,310,000
5,077,000
5,537,000
5,396,000
Operating expenses
Research development
228,624
229,000
221,000
194,000
168,000
Selling general and administrative
3,784,634
3,784,000
3,096,000
3,165,000
3,061,000
Total operating expenses
4,013,258
4,013,000
3,317,000
3,359,000
3,229,000
Operating income or loss
1,296,994
1,297,000
1,760,000
2,178,000
2,167,000
Interest expense
360,139
360,000
353,000
410,000
491,000
Total other income/expenses net
214,761
215,000
92,000
126,000
103,000
Income before tax
1,219,279
1,220,000
1,572,000
1,936,000
1,841,000
Income tax expense
324,954
325,000
353,000
501,000
402,000
Income from continuing operations
894,325
895,000
1,219,000
1,435,000
1,439,000
Net income
673,405
673,000
969,000
1,164,000
1,200,000
Net income available to common shareholders
673,405
673,000
969,000
1,164,000
1,200,000
Basic EPS
-
1.15
1.66
1.98
1.98
Diluted EPS
-
1.15
1.66
1.98
1.98
Basic average shares
-
586,493
585,889
588,111
605,383
Diluted average shares
-
586,493
585,889
588,111
605,383
EBITDA
-
1,580,000
1,925,000
2,346,000
2,332,000